TMCI NASDAQ
Treace Medical Concepts, Inc.
1W: +11.8%
1M: +1.6%
3M: +12.6%
YTD: +82.0%
1Y: -33.8%
3Y: -54.1%
5Y: -82.1%
$4.55
+0.13 (+2.94%)
Weekly Expected Move ±8.2%
$4
$4
$4
$5
$5
Credit Risk of going bust: higher than 81% of companies Debt: 19.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.16 (down 97%), Treace Medical Concepts, Inc. would be worth roughly what it owes.
Total debt $72.7M against a stock market value of $295.9M.
Distance to default 2.55 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $31.2M (short-term plus half of long-term), stock volatility 88.9%; Altman Z 0.06. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.16 (down 97%), Treace Medical Concepts, Inc. would be worth roughly what it owes.
Total debt $72.7M against a stock market value of $295.9M.
Distance to default 2.55 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $31.2M (short-term plus half of long-term), stock volatility 88.9%; Altman Z 0.06. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-06-13
Earliest Filing
2025-12-18
Latest Filing
partner: 1
target: 1
Counterparties (Filed by TMCI)
2 relationshipsCompanies named in TMCI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Armentum Partners | — | partner | Financial advisor to Treace on the transaction. | 2025-12-18 | View |
| MIOS Marketing, LLC d/b/a RedPoint Medical3d | — | target | Target of asset acquisition for pre-operative planning and patient-specific guides assets. | 2023-06-13 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-07 | Earnings Release; Exhibits | View | |
| 2026-05-20 | Shareholder Vote; Exhibits | View | |
| 2026-05-08 | Earnings Release; Exhibits | View | |
| 2026-04-09 | Earnings Release; Officer/Director Change; Regulation FD | View | |
| 2026-02-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-12-18 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of | Agreement | View |
| 2025-11-06 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-21 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-07 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-02-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-15 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-05-22 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2024-01-10 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-01-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR